Guangyuan Zhao

机构：Hebei Medical University, Northwestern University, Ministry of Education, Midwestern University, Sun Yat-sen University, Huawei Technologies (China), Northwestern University, Xingtai People's Hospital, The First Affiliated Hospital, Sun Yat-sen University, Northwestern Medicine · ORCID：0000-0002-1095-8875

发表论文 80 篇 · 总被引 1703 次 · h-index 18

代表论文

• A Novel Daratumumab-Based Regimen for Desensitization in Highly HLA-Presensitized Patients Awaiting Kidney Transplantation (2023 · Transplant International · 被引 13)
• Comparative transcriptomic, epigenomic and immunological analyses identify drivers of disparity in high-grade serous ovarian cancer (2024 · npj Genomic Medicine · 被引 8)
• Discovery of Novel Imidazo[1,2- a ]pyridine-Based HDAC6 Inhibitors as an Anticarcinogen with a Cardioprotective Effect (2024 · Journal of Medicinal Chemistry · 被引 8)
• Metabolic Dependency on De Novo Pyrimidine Synthesis Is a Targetable Vulnerability in Platinum-Resistant Ovarian Cancer (2025 · Cancer Research · 被引 7)
• Complement activation at the interface between adipocytes and cancer cells drives tumor progression (2025 · JCI Insight · 被引 7)
• E2F1 mediates competition, proliferation and response to cisplatin in cohabitating resistant and sensitive ovarian cancer cells (2024 · Frontiers in Oncology · 被引 6)